The variable in common variable immunodeficiency: A disease of complex phenotypes

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 6, 2013, Pages 545-556

  Jolles, Stephen ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Antibody deficiency; Biomarker; Common variable immunodeficiency; Immunoglobulin; Primary immunodeficiency

Indexed keywords

AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; BIOLOGICAL MARKER; BUDESONIDE; CORTICOSTEROID; CYANOCOBALAMIN; FLUTICASONE; HAEMOPHILUS VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PNEUMOCOCCUS VACCINE; PREDNISOLONE; RITUXIMAB; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; AUTOIMMUNE DISEASE; CANCER RISK; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; CYANOCOBALAMIN DEFICIENCY; CYTOPENIA; DELAYED DIAGNOSIS; ENTERITIS; ENTEROPATHY; GENETIC ASSOCIATION; HUMAN; INFECTION; INFLAMMATION; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; MORTALITY; PROGNOSIS; RESPIRATORY TRACT INFECTION; COMPLICATION; FORECASTING; GASTROINTESTINAL DISEASES; LUNG DISEASES; METABOLISM; NEOPLASMS; PATIENT REFERRAL; PHENOTYPE; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT;

BIOLOGICAL MARKERS; COMMON VARIABLE IMMUNODEFICIENCY; DELAYED DIAGNOSIS; FORECASTING; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOGLOBULINS; LUNG DISEASES; NEOPLASMS; PHENOTYPE; REFERRAL AND CONSULTATION; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT;

EID: 84887011778     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.09.015     Document Type: Article

References (117)

1. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010, 116:7-15.
2. Moschese V., Graziani S., Avanzini M.A., Carsetti R., Marconi M., La Rocca M., et al. Aprospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network. Int J Immunopathol Pharmacol 2008, 21:343-352.
3. van der Burg M., Gennery A.R. Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency. Eur J Pediatr 2011, 170:561-571.
4. Al-Muhsen S., Casanova J.L. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. JAllergy Clin Immunol 2008, 122:1043-1051. quiz 52-3.
5. Volanakis J.E., Zhu Z.B., Schaffer F.M., Macon K.J., Palermos J., Barger B.O., et al. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. JClin Invest 1992, 89:1914-1922.
6. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261-268.
7. van Zelm M.C., Reisli I., van der Burg M., Castano D., van Noesel C.J., van Tol M.J., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. NEngl J Med 2006, 354:1901-1912.
8. Warnatz K., Salzer U., Rizzi M., Fischer B., Gutenberger S., Bohm J., et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009, 106:13945-13950.
9. Kuijpers T.W., Bende R.J., Baars P.A., Grummels A., Derks I.A., Dolman K.M., et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. JClin Invest 2010, 120:214-222.
10. Thiel J., Kimmig L., Salzer U., Grudzien M., Lebrecht D., Hagena T., et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. JAllergy Clin Immunol 2012, 129:801-810.e6.
11. van Zelm M.C., Smet J., Adams B., Mascart F., Schandene L., Janssen F., et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. JClin Invest 2010, 120:1265-1274.
12. Lopez-Herrera G., Tampella G., Pan-Hammarstrom Q., Herholz P., Trujillo-Vargas C.M., Phadwal K., et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 2012, 90:986-1001.
13. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005, 37:829-834.
14. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005, 37:820-828.
15. Salzer U., Warnatz K., Peter H.H. Common variable immunodeficiency: an update. Arthritis Res Ther 2012, 14:223.
16. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34-48.
17. Chapel H., Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009, 145:709-727.
18. Conley M.E., Notarangelo L.D., Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999, 93:190-197.
19. Verbsky J.W., Baker M.W., Grossman W.J., Hintermeyer M., Dasu T., Bonacci B., et al. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011). JClin Immunol 2012, 32:82-88.
20. Borte S., von Dobeln U., Fasth A., Wang N., Janzi M., Winiarski J., et al. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012, 119:2552-2555.
21. Borte S., Janzi M., Pan-Hammarstrom Q., von Dobeln U., Nordvall L., Winiarski J., et al. Placental transfer of maternally-derived IgA precludes the use of guthrie card eluates as a screening tool for primary immunodeficiency diseases. PLoS One 2012, 7:e43419.
22. Corcoran R.M., Durnan S.M. Albumin determination by a modified bromcresol green method. Clin Chem 1977, 23:765-766.
23. Bright P., Lock R.J., Unsworth D.J. Immunoglobulin A deficiency on serological coeliac screening: an opportunity for early diagnosis of hypogammaglobulinaemia. Ann Clin Biochem 2012, 49:503-504.
24. Unsworth D.J., Virgo P.F., Lock R.J. Immunoglobulin E deficiency: a forgotten clue pointing to possible immunodeficiency?. Ann Clin Biochem 2011, 48:459-461.
25. Cunningham-Rundles C., Sidi P., Estrella L., Doucette J. Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes. JAllergy Clin Immunol 2004, 113:747-755.
26. Subbarayan A., Colarusso G., Hughes S.M., Gennery A.R., Slatter M., Cant A.J., et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics 2011, 127:810-816.
27. Healy M.J. Hypogammaglobulinaemia in the United Kingdom. XII. Statistical analyses: prevalence, mortality and effects of treatment. Spec Rep Ser Med Res Counc (G B) 1971, 310:115-123.
28. Hermaszewski R.A., Webster A.D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. QJ Med 1993, 86:31-42.
29. Resnick E.S., Moshier E.L., Godbold J.H., Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012, 119:1650-1657.
30. Chapel H., Lucas M., Lee M., Bjorkander J., Webster D., Grimbacher B., et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008, 112:277-286.
31. Chapel H., Lucas M., Patel S., Lee M., Cunningham-Rundles C., Resnick E., et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. JAllergy Clin Immunol 2012, 130. 1197-8.e9.
32. Ardeniz O., Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol 2009, 133:198-207.
33. Arnold D.F., Wiggins J., Cunningham-Rundles C., Misbah S.A., Chapel H.M. Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin Immunol 2008, 128:18-22.
34. Wong G.K., Goldacker S., Winterhalter C., Grimbacher B., Chapel H., Lucas M., et al. Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients. Clin Exp Immunol 2013, 172:63-72.
35. Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77-85.
36. Klein U., Rajewsky K., Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. JExp Med 1998, 188:1679-1689.
37. Agematsu K., Nagumo H., Shinozaki K., Hokibara S., Yasui K., Terada K., et al. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. JClin Invest 1998, 102:853-860.
38. Park J.Y., Shcherbina A., Rosen F.S., Prodeus A.P., Remold-O'Donnell E. Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol 2005, 139:297-305.
39. Ma C.S., Pittaluga S., Avery D.T., Hare N.J., Maric I., Klion A.D., et al. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. JClin Invest 2006, 116:322-333.
40. Malaspina A., Moir S., Chaitt D.G., Rehm C.A., Kottilil S., Falloon J., et al. Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 2007, 109:2086-2088.
41. Bleesing J.J., Souto-Carneiro M.M., Savage W.J., Brown M.R., Martinez C., Yavuz S., et al. Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment. JImmunol 2006, 176:7096-7103.
42. Herbst E.W., Armbruster M., Rump J.A., Buscher H.P., Peter H.H. Intestinal B cell defects in common variable immunodeficiency. Clin Exp Immunol 1994, 95:215-221.
43. Ochtrop M.L., Goldacker S., May A.M., Rizzi M., Draeger R., Hauschke D., et al. Tand B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood 2011, 118:309-318.
44. Sanchez-Ramon S., Radigan L., Yu J.E., Bard S., Cunningham-Rundles C. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 2008, 128:314-321.
45. Taubenheim N., von Hornung M., Durandy A., Warnatz K., Corcoran L., Peter H.H., et al. Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients. JImmunol 2005, 175:5498-5503.
46. Giovannetti A., Pierdominici M., Mazzetta F., Marziali M., Renzi C., Mileo A.M., et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. JImmunol 2007, 178:3932-3943.
47. Malphettes M., Gerard L., Carmagnat M., Mouillot G., Vince N., Boutboul D., et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009, 49:1329-1338.
48. Orange J.S., Glessner J.T., Resnick E., Sullivan K.E., Lucas M., Ferry B., et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. JAllergy Clin Immunol 2011, 127:1360-1367.e6.
49. Bjork A.H., Oskarsdottir S., Andersson B.A., Friman V. Antibody deficiency in adults with 22q11.2 deletion syndrome. Am J Med Genet A 2012, 158A:1934-1940.
50. Kainulainen L., Nikoskelainen J., Vuorinen T., Tevola K., Liippo K., Ruuskanen O. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999, 159:1199-1204.
51. Kainulainen L., Vuorinen T., Rantakokko-Jalava K., Osterback R., Ruuskanen O. Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. JAllergy Clin Immunol 2010, 126:120-126.
52. Curtin J.J., Webster A.D., Farrant J., Katz D. Bronchiectasis in hypogammaglobulinaemia-a computed tomography assessment. Clin Radiol 1991, 44:82-84.
53. Kainulainen L., Varpula M., Liippo K., Svedstrom E., Nikoskelainen J., Ruuskanen O. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. JAllergy Clin Immunol 1999, 104:1031-1036.
54. Tanaka N., Kim J.S., Bates C.A., Brown K.K., Cool C.D., Newell J.D., et al. Lung diseases in patients with common variable immunodeficiency: chest radiographic, and computed tomographic findings. JComput Assist Tomogr 2006, 30:828-838.
55. Hampson F.A., Chandra A., Screaton N.J., Condliffe A., Kumararatne D.S., Exley A.R., et al. Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders. Clin Radiol 2012, 67:587-595.
56. Chen Y., Stirling R.G., Paul E., Hore-Lacy F., Thompson B.R., Douglass J.A. Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies. JAllergy Clin Immunol 2011, 127:1414-1417.
57. Gregersen S., Aalokken T.M., Mynarek G., Fevang B., Holm A.M., Ueland T., et al. Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. Ann Allergy Asthma Immunol 2010, 104:503-510.
58. Detkova D., de Gracia J., Lopes-da-Silva S., Vendrell M., Alvarez A., Guarner L., et al. Common variable immunodeficiency: association between memory B cells and lung diseases. Chest 2007, 131:1883-1889.
59. Popa V., Colby T.V., Reich S.B. Pulmonary interstitial disease in Ig deficiency. Chest 2002, 122:1594-1603.
60. Gregersen S., Aalokken T.M., Mynarek G., Kongerud J., Aukrust P., Froland S.S., et al. High resolution computed tomography and pulmonary function in common variable immunodeficiency. Respir Med 2009, 103:873-880.
61. Wislez M., Sibony M., Naccache J.M., Liote H., Carette M.F., Oksenhendler E., et al. Organizing pneumonia related to common variable immunodeficiency. Case report and literature review. Respiration 2000, 67:467-470.
62. Bates C.A., Ellison M.C., Lynch D.A., Cool C.D., Brown K.K., Routes J.M. Granulomatous-lymphocytic lung disease shortens survival in common variableimmunodeficiency. JAllergy Clin Immunol 2004, 114:415-421.
63. Park J.E., Beal I., Dilworth J.P., Tormey V., Haddock J. The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency. Eur J Radiol 2005, 54:359-364.
64. Chase N.M., Verbsky J.W., Hintermeyer M.K., Waukau J.K., Tomita-Mitchell A., Casper J.T., et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). JClin Immunol 2013, 33:30-39.
65. Aghamohammadi A., Moin M., Kouhi A., Mohagheghi M.A., Shirazi A., Rezaei N., et al. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology 2008, 213:447-454.
66. Palanduz S., Palanduz A., Yalcin I., Somer A., Ones U., Ustek D., et al. In vitro chromosomal radiosensitivity in common variable immune deficiency. Clin Immunol Immunopathol 1998, 86:180-182.
67. Vorechovsky I., Scott D., Haeney M.R., Webster D.A. Chromosomal radiosensitivity in common variable immune deficiency. Mutat Res 1993, 290:255-264.
68. Serra G., Milito C., Mitrevski M., Granata G., Martini H., Pesce A.M., et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest 2011, 140:1581-1589.
69. Aslam A., Misbah S.A., Talbot K., Chapel H. Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency. Clin Immunol 2004, 112:24-29.
70. Mavrommatis B., Young G.R., Kassiotis G. Counterpoise between the microbiome, host immune activation and pathology. Curr Opin Immunol 2013, 25:456-462.
71. Quinti I., Soresina A., Guerra A., Rondelli R., Spadaro G., Agostini C., et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. JClin Immunol 2011, 31:315-322.
72. Abo W., Chiba S., Yamanaka T., Nakao T., Hara M., Tagaya I. Paralytic poliomyelitis in a child with agammaglobulinemia. Eur J Pediatr 1979, 132:11-16.
73. Hara M., Saito Y., Komatsu T., Kodama H., Abo W., Chiba S., et al. Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration. Microbiol Immunol 1981, 25:905-913.
74. MacLennan C., Dunn G., Huissoon A.P., Kumararatne D.S., Martin J., O'Leary P., et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 2004, 363:1509-1513.
75. Agarwal S., Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. JAllergy Clin Immunol 2009, 124:658-664.
76. Daniels J.A., Lederman H.M., Maitra A., Montgomery E.A. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007, 31:1800-1812.
77. Washington K., Stenzel T.T., Buckley R.H., Gottfried M.R. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 1996, 20:1240-1252.
78. Agarwal S., Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis 2010, 16:703-711.
79. Kainulainen L., Nikoskelainen J., Ruuskanen O. Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. JClin Immunol 2001, 21:145-149.
80. Malamut G., Verkarre V., Suarez F., Viallard J.F., Lascaux A.S., Cosnes J., et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010, 105:2262-2275.
81. Packwood K., Drewe E., Staples E., Webster D., Witte T., Litzman J., et al. NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders. Clin Exp Immunol 2010, 161:536-541.
82. van de Ven A.A., Hoytema van Konijnenburg D.P., Wensing A.M., van Montfrans J.M. The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy. Clin Rev Allergy Immunol 2012, 42:79-91.
83. Chua I., Standish R., Lear S., Harbord M., Eren E., Raeiszadeh M., et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2007, 150:306-311.
84. Boursiquot J.N., Gerard L., Malphettes M., Fieschi C., Galicier L., Boutboul D., et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. JClin Immunol 2013, 33:84-95.
85. Malamut G., Ziol M., Suarez F., Beaugrand M., Viallard J.F., Lascaux A.S., et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. JHepatol 2008, 48:74-82.
86. Ward C., Lucas M., Piris J., Collier J., Chapel H. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 2008, 153:331-337.
87. Aukrust P., Muller F., Ueland T., Svardal A.M., Berge R.K., Froland S.S. Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses. Eur J Clin Invest 2000, 30:252-259.
88. Indrevaer R.L., Holm K.L., Aukrust P., Osnes L.T., Naderi E.H., Fevang B., et al. Retinoic acid improves defective TLR9/RP105-induced immune responses in common variable immunodeficiency-derived B cells. JImmunol 2013, 191:3624-3633.
89. van de Ven A.A., Douma J.W., Rademaker C., van Loon A.M., Wensing A.M., Boelens J.J., et al. Pleconaril-resistant chronic Parechovirus-associated enteropathy in agammaglobulinaemia. Antivir Ther 2011, 16:611-614.
90. Zullo A., Romiti A., Rinaldi V., Vecchione A., Tomao S., Aiuti F., et al. Gastric pathology in patients with common variable immunodeficiency. Gut 1999, 45:77-81.
91. Dhalla F., da Silva S.P., Lucas M., Travis S., Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 2011, 165:1-7.
92. Roifman C.M., Levison H., Gelfand E.W. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1987, I:1075-1077.
93. Orange J.S., Belohradsky B.H., Berger M., Borte M., Hagan J., Jolles S., et al. Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy. Clin Exp Immunol 2012, 169:172-181.
94. Orange J.S., Grossman W.J., Navickis R.J., Wilkes M.M. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol 2010, 137:21-30.
95. Berger M., Murphy E., Riley P., Bergman G.E. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G. South Med J 2010, 103:856-863.
96. Shapiro R.S. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics. Pediatr Allergy Immunol 2013, 24:49-53.
97. Wasserman R.L., Melamed I., Stein M.R., Gupta S., Puck J., Engl W., et al. Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. JAllergy Clin Immunol 2012, 130:951-957.e11.
98. Jolles S. Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency. Immunotargets Ther 2013, 2:125-133.
99. Kim J., Hayton W.L., Robinson J.M., Anderson C.L. Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model. Clin Immunol 2007, 122:146-155.
100. Gouilleux-Gruart V., Chapel H., Chevret S., Lucas M., Malphettes M., Fieschi C., et al. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor. Clin Exp Immunol 2013, 171:186-194.
101. Freiberger T., Grodecka L., Ravcukova B., Kurecova B., Postranecka V., Vlcek J., et al. Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency. Clin Immunol 2010, 136:419-425.
102. Lucas M., Lee M., Lortan J., Lopez-Granados E., Misbah S., Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. JAllergy Clin Immunol 2010, 125:1354-1360.e4.
103. Yel L. Selective IgA deficiency. JClin Immunol 2010, 30:10-16.
104. Bonagura V.R., Marchlewski R., Cox A., Rosenthal D.W. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. JAllergy Clin Immunol 2008, 122:210-212.
105. Teh C.E., Horikawa K., Arnold C.N., Beutler B., Kucharska E.M., Vinuesa C.G., et al. Heterozygous mis-sense mutations in Prkcb as a critical determinant of anti-polysaccharide antibody formation. Genes Immun 2013, 14:223-233.
106. Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program 2012, 2012:301-305.
107. Fevang B., Mollnes T.E., Holm A.M., Ueland T., Heggelund L., Damas J.K., et al. Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis. Clin Exp Immunol 2005, 142:576-584.
108. Knight A.K., Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 2006, 5:156-159.
109. Bateman E.A., Ayers L., Sadler R., Lucas M., Roberts C., Woods A., et al. Tcell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 2012, 170:202-211.
110. Arumugakani G., Wood P.M., Carter C.R. Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes. JClin Immunol 2010, 30:292-300.
111. Carter C.R., Aravind G., Smalle N.L., Cole J.Y., Savic S., Wood P.M. CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells. JClin Pathol 2013, 66:146-150.
112. Horn J., Manguiat A., Berglund L.J., Knerr V., Tahami F., Grimbacher B., et al. Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 2009, 156:446-454.
113. Melo K.M., Carvalho K.I., Bruno F.R., Ndhlovu L.C., Ballan W.M., Nixon D.F., et al. Adecreased frequency of regulatory T cells in patients with common variable immunodeficiency. PLoS One 2009, 4:e6269.
114. Visentini M., Cagliuso M., Conti V., Carbonari M., Mancaniello D., Cibati M., et al. Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency. Eur J Immunol 2011, 41:854-862.
115. Mullighan C.G., Marshall S.E., Welsh K.I. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 2000, 51:111-122.
116. Mullighan C.G., Fanning G.C., Chapel H.M., Welsh K.I. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. JImmunol 1997, 159:6236-6241.
117. Chew G.Y., Sinha U., Gatenby P.A., DeMalmanche T., Adelstein S., Garsia R., et al. Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22). JAllergy Clin Immunol 2013, 131:1130-1135.e1.